Logo-jcvtr

J Cardiovasc Thorac Res. 2020;12(3): 209-213. doi: 10.34172/jcvtr.2020.35
PMID: 33123327        PMCID: PMC7581847

Original Article

Pregnancy outcome in women with mechanical prosthetic heart valvesat their first trimester of pregnancy treated with unfractionated heparin (UFH) or enoxaparin: A randomized clinical trial

Minoo Movahedi 1, Maryam Motamedi 1 ORCID, Amirreza Sajjadieh 2 * ORCID, Parvin Bahrami 2 ORCID, Mahmood Saeedi 3, Milad Saeedi 4

Cited by CrossRef: 2

1- Yang D, Zhang H, Zeng J, Liang X, Luo L, Song Y, Tian B, Li Y, Han J, Zhang J. Pregnancy outcomes in women with prosthetic heart valves: A single-center study in China. 2025;104(23):e42622 [Crossref]
2- Shishesaz M, Eshraghi R, Bahrami A, Farzan M, Farzan M, Hajibeygi R, Fathi M, Yaghoobpoor S, Tavasol A, Gorjizad M, Dehghani M, Akbari A, Rafiei N, Roostaie M, Eslami S, Taherkhani M, Movahed M. The effectiveness and side effects of anti-coagulant drugs in pregnant women with mechanical or bio-prosthetic heart valves: A systematic review and meta-analysis study. Journal of Cardiology. 2025; [Crossref]
3- Middleton P, Shepherd E, Gomersall J. Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period. 2021;2021(3) [Crossref]
4- Rutz T, Eggel-Hort B, Alberio L, Bouchardy J. Anticoagulation of women with congenital heart disease during pregnancy. International Journal of Cardiology Congenital Heart Disease. 2021;5:100210 [Crossref]